Oncology Series Seminars
Event Information
About this Event
Oncology Series
Since 2002 Dr. Weber has been giving seminars to professionals on the subject of oncology.
Daniel Weber’s work did not go unnoticed in China. Tianjin University invited Daniel to become Visiting Professor and the World Federation of Chinese Medicine Societies selected Daniel as their Vice-Chair Oncology. Tirelessly Daniel has invented systems and tools to help make prescribing for cancer patients easier, through the publication of four books with online version, and recently through the highly acclaimed BOTANICAL ONCOLOGY APP.
Registration and lunch from 12 pm
Biometric Pathways in Breast Cancer: Treating the Patient and the Disease
The breast cancer stem cell (BCSC) hypothesis has grown in the cancer research community. These BCSCs comprise of a small subpopulation of
cells within the tumour mass which exhibit stem cell-like characteristics and have emerged as being responsible for tumour development, recurrence and metastasis in BCa. The complexity of control of gene expression in BCSC is commonly driven by a myriad of signalling pathways triggered by extracellular signals, mutations and epigenetic control. Thus, some signalling pathways have been highlighted in BCa.
Nuclear factor-kappa B (NFk-B), signal transducer and activator of transcription 3 (STAT-3), wingless-type MMTV integration site family (Wnt)/β- catenin, Hedgehog and NOTCH.
Moreover, these cells can also be influenced by the tumour microenvironment, for instance, hypoxia (HIF-1), VEGF, inflammatory cytokines including TNF-a, myriad coagulation factors and other bio-pathways. Given the importance
of signalling pathways and tumour microenvironment for breast cancer, this seminar focuses on the relationship between cellular signalling and BCSCs and its therapeutic implications.
About Daniel Weber, DSc, PhD
Daniel Weber is CEO of Panaxea International and Visiting Professor at Tianjin University, where he conducts research into triple negative breast cancer and botanical isolates. He is Vice-Chair of oncology with the World Federation of Chinese Medicine Societies.
Daniel is also a consultant to the International Consortium for Chinese Medicine and Cancer, at the Office of Cancer Complementary and Alternative Medicine, the National Cancer Institute.
Daniel is a world renowned expert on
Botanical and Integrative Oncology and
has written a number of books, articles
and databases on complementary oncology and lectures extensively to both medical doctors and CAM practitioners on the subject. He lectures
at a number of universities in Australia as well as the USA, including the University of New South Wales, the University of Technology Sydney, Bastyr University and the Pacific College of Oriental Medicine. Daniel consults in his clinical practice in Sydney.
Some of the seminars and webinars related to oncology that are still available, contact Panaxea office.
